The effect of indomethacin tocolysis on maternal coagulation statu

C. C. Lunt, A. J. Satin, W. H. Barth, Gary Hankins

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: To investigate the effect of indomethacin tocolysis on maternal coagulation Methods: Twenty gravidas at 24-32 weeks' gestation were treated for preterm labor with 50 mg indomethacin orally, followed by 25 mg every 6 hours for 3 days. Bleeding time, prothrombin time (FT), and activated partial thromboplastin time (aPTT) were measured before and 48 hours after initiation of therapy. Statistical analysis was performed by paired t test and Fisher exact test. Results: The typical participant was 22 years old, nulliparous, and 26.2 weeks' gestational age at enrollment. The mean bleeding time was 4.5 minutes before therapy and 8.8 minutes after therapy (P < .0001, mean difference 4.3 minutes, 95% confidence interval 2.9-5.8). Nineteen of the 20 subjects experienced an increase in bleeding time and 13 had abnormal bleeding times. No clinically significant changes in PT or aPTT were noted. The mean period from treatment to delivery was 60.2 days. No cases of neonatal intraventricular hemorrhage or maternal postpartum hemorrhage were noted. Conclusion: Oral indomethacin treatment for tocolysis has no impact on PT and aPTT; however, profound acute changes in maternal bleeding time occur.

Original languageEnglish (US)
Pages (from-to)820-822
Number of pages3
JournalObstetrics and Gynecology
Volume84
Issue number5
StatePublished - 1994
Externally publishedYes

Fingerprint

Tocolysis
Bleeding Time
Indomethacin
Mothers
Partial Thromboplastin Time
Therapeutics
Postpartum Hemorrhage
Premature Obstetric Labor
Prothrombin Time
Gestational Age
Confidence Intervals
Hemorrhage
Pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Lunt, C. C., Satin, A. J., Barth, W. H., & Hankins, G. (1994). The effect of indomethacin tocolysis on maternal coagulation statu. Obstetrics and Gynecology, 84(5), 820-822.

The effect of indomethacin tocolysis on maternal coagulation statu. / Lunt, C. C.; Satin, A. J.; Barth, W. H.; Hankins, Gary.

In: Obstetrics and Gynecology, Vol. 84, No. 5, 1994, p. 820-822.

Research output: Contribution to journalArticle

Lunt, CC, Satin, AJ, Barth, WH & Hankins, G 1994, 'The effect of indomethacin tocolysis on maternal coagulation statu', Obstetrics and Gynecology, vol. 84, no. 5, pp. 820-822.
Lunt CC, Satin AJ, Barth WH, Hankins G. The effect of indomethacin tocolysis on maternal coagulation statu. Obstetrics and Gynecology. 1994;84(5):820-822.
Lunt, C. C. ; Satin, A. J. ; Barth, W. H. ; Hankins, Gary. / The effect of indomethacin tocolysis on maternal coagulation statu. In: Obstetrics and Gynecology. 1994 ; Vol. 84, No. 5. pp. 820-822.
@article{514afd7a9430495ea84aa7a2eeed0281,
title = "The effect of indomethacin tocolysis on maternal coagulation statu",
abstract = "Objective: To investigate the effect of indomethacin tocolysis on maternal coagulation Methods: Twenty gravidas at 24-32 weeks' gestation were treated for preterm labor with 50 mg indomethacin orally, followed by 25 mg every 6 hours for 3 days. Bleeding time, prothrombin time (FT), and activated partial thromboplastin time (aPTT) were measured before and 48 hours after initiation of therapy. Statistical analysis was performed by paired t test and Fisher exact test. Results: The typical participant was 22 years old, nulliparous, and 26.2 weeks' gestational age at enrollment. The mean bleeding time was 4.5 minutes before therapy and 8.8 minutes after therapy (P < .0001, mean difference 4.3 minutes, 95{\%} confidence interval 2.9-5.8). Nineteen of the 20 subjects experienced an increase in bleeding time and 13 had abnormal bleeding times. No clinically significant changes in PT or aPTT were noted. The mean period from treatment to delivery was 60.2 days. No cases of neonatal intraventricular hemorrhage or maternal postpartum hemorrhage were noted. Conclusion: Oral indomethacin treatment for tocolysis has no impact on PT and aPTT; however, profound acute changes in maternal bleeding time occur.",
author = "Lunt, {C. C.} and Satin, {A. J.} and Barth, {W. H.} and Gary Hankins",
year = "1994",
language = "English (US)",
volume = "84",
pages = "820--822",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - The effect of indomethacin tocolysis on maternal coagulation statu

AU - Lunt, C. C.

AU - Satin, A. J.

AU - Barth, W. H.

AU - Hankins, Gary

PY - 1994

Y1 - 1994

N2 - Objective: To investigate the effect of indomethacin tocolysis on maternal coagulation Methods: Twenty gravidas at 24-32 weeks' gestation were treated for preterm labor with 50 mg indomethacin orally, followed by 25 mg every 6 hours for 3 days. Bleeding time, prothrombin time (FT), and activated partial thromboplastin time (aPTT) were measured before and 48 hours after initiation of therapy. Statistical analysis was performed by paired t test and Fisher exact test. Results: The typical participant was 22 years old, nulliparous, and 26.2 weeks' gestational age at enrollment. The mean bleeding time was 4.5 minutes before therapy and 8.8 minutes after therapy (P < .0001, mean difference 4.3 minutes, 95% confidence interval 2.9-5.8). Nineteen of the 20 subjects experienced an increase in bleeding time and 13 had abnormal bleeding times. No clinically significant changes in PT or aPTT were noted. The mean period from treatment to delivery was 60.2 days. No cases of neonatal intraventricular hemorrhage or maternal postpartum hemorrhage were noted. Conclusion: Oral indomethacin treatment for tocolysis has no impact on PT and aPTT; however, profound acute changes in maternal bleeding time occur.

AB - Objective: To investigate the effect of indomethacin tocolysis on maternal coagulation Methods: Twenty gravidas at 24-32 weeks' gestation were treated for preterm labor with 50 mg indomethacin orally, followed by 25 mg every 6 hours for 3 days. Bleeding time, prothrombin time (FT), and activated partial thromboplastin time (aPTT) were measured before and 48 hours after initiation of therapy. Statistical analysis was performed by paired t test and Fisher exact test. Results: The typical participant was 22 years old, nulliparous, and 26.2 weeks' gestational age at enrollment. The mean bleeding time was 4.5 minutes before therapy and 8.8 minutes after therapy (P < .0001, mean difference 4.3 minutes, 95% confidence interval 2.9-5.8). Nineteen of the 20 subjects experienced an increase in bleeding time and 13 had abnormal bleeding times. No clinically significant changes in PT or aPTT were noted. The mean period from treatment to delivery was 60.2 days. No cases of neonatal intraventricular hemorrhage or maternal postpartum hemorrhage were noted. Conclusion: Oral indomethacin treatment for tocolysis has no impact on PT and aPTT; however, profound acute changes in maternal bleeding time occur.

UR - http://www.scopus.com/inward/record.url?scp=0028143782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028143782&partnerID=8YFLogxK

M3 - Article

VL - 84

SP - 820

EP - 822

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 5

ER -